Contraline
Charlottesville, Virginia, United States · Biotechnology, Clothing And Apparel, Commerce And Shopping
Contraline, Inc. is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception. The company is developing ADAMTM, the world’s first injectable hydrogel designed to provide long-lasting barrier contraception for men. The company was founded in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, V
Key facts
- Headquarters
- Charlottesville, Virginia, United States
- Employees
- 25
- Industries
- Biotechnology, Clothing And Apparel, Commerce And Shopping
- Status
- Private
- Website
- contraline.com
- Company page
Recent activity at Contraline
- : Contraline has secured $92.5 million in Series B financing, co-led by BVF Partners and RA Capital Management, to advance its NES/T male contraceptive into late-stage development.
- : Contraline & Population Council Announce Option-to-License Agreement for Male Contraceptive (date Fundz recorded it)
- : Contraline, Inc.
- : Contraline Closes $10.7 Million Series A Financing To Become A Clinical Stage Company
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Contraline funding history
| Date | Round | Amount |
|---|---|---|
| May 2026 | Series B | $92.5M |
| Apr 2022 | Venture | $7.2M |
| Oct 2021 | Series A | $10.7M |
Leadership
- Kevin, Co-Founder and CEO
- Ted Looney, Director of Finance and Business Development
- Kevin Eisenfrats, Executive Officer, Director, Promoter
- Tom Thorpe, Director
- Martin Emerson, Director
- Michael King, Director
- Gurdane Bhutani, Director
- Justin Mattice, Chief Commercial Officer
- Joseph Fernandes, Executive Officer
- Nhi Nguyen, Executive Officer
- Finally Fund Admin LLC, Director
Verified email and direct lines for Contraline’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Contraline files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Contraline in the news
- Contraline and its male birth control candidate rally $92.5M amid push into 'massive white space' of men's health - Fierce Pharma (Jun 02, 2026)
- ADAM, a long-term, injectable male birth control, shows promise at AUA 2025 - Urology Times (Apr 26, 2025)
- Contraline Announces $92.5 Million Series B Financing to Advance NES/T Male Contraceptive into Late-Stage Development - Yahoo Finance (Jun 02, 2026)
- Male Birth Control: Moving Beyond the Dual-Option Contraceptive Toolkit - Endocrinology Advisor (Jun 22, 2026)
- DNA Diagnostics Center Partners with Contraline in ADAMTM Clinical Trial, Testing Revolutionary Male Contraceptive - BioSpace (Jun 21, 2024)
- Trial Data Looks Promising for ‘IUD For Men’ - MedCity News (Jan 04, 2024)
- Male contraception: Moving beyond missteps, misconceptions - Contemporary OB/GYN (Apr 03, 2024)
- A Gel Injected Into the Scrotum Could Be the Next Male Contraceptive - WIRED (Jan 04, 2024)
Companies similar to Contraline
- Hungry Panda · Commerce And Shopping, Mobile, Other
- Tradesy, Inc. · Clothing And Apparel, Commerce And Shopping, Other
- DYRT, INC. · Commerce And Shopping, Mobile, Other
- Formulate · Commerce And Shopping, Mobile, Other
- Circ, INC. · Clothing And Apparel, Commerce And Shopping, Other
About Contraline: questions and answers
What does Contraline do?
Contraline, Inc. is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception. The company is developing ADAMTM, the world’s first injectable hydrogel designed to provide long-lasting barrier contraception for men. The company was founded in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, V
Where is Contraline headquartered?
Contraline is headquartered in Charlottesville, Virginia, United States.
How many employees does Contraline have?
Contraline has about 25 employees.
Has Contraline raised funding?
Yes. Fundz has recorded 3 funding events for Contraline. The most recent, Series B of $92.5M, was in May 2026.
Who leads Contraline?
Kevin is a Co-Founder and CEO at Contraline.
What is the latest news on Contraline?
On May 29, 2026, Contraline has secured $92.5 million in Series B financing, co-led by BVF Partners and RA Capital Management, to advance its NES/T male contraceptive into late-stage development.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy